(-1.57%) 5 035.69 points
(-1.49%) 37 816 points
(-2.04%) 15 658 points
(-0.94%) $81.16
(-2.21%) $1.947
(-0.24%) $2 297.30
(0.25%) $26.72
(-0.50%) $943.50
(0.14%) $0.938
(0.28%) $11.13
(0.16%) $0.802
(0.00%) $93.45
0.77% ¥ 2 354.00
Live Chart Being Loaded With Signals
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally...
Stats | |
---|---|
Dagens volum | 298 500 |
Gjennomsnittsvolum | 453 259 |
Markedsverdi | 439.89B |
EPS | ¥0 ( 2024-02-07 ) |
Neste inntjeningsdato | ( ¥38.32 ) 2024-05-13 |
Last Dividend | ¥29.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 14.53 |
ATR14 | ¥1.349 (0.06%) |
Volum Korrelasjon
Alfresa Holdings Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Alfresa Holdings Korrelasjon - Valuta/Råvare
Alfresa Holdings Økonomi
Annual | 2022 |
Omsetning: | ¥2 696.07B |
Bruttogevinst: | ¥192.09B (7.12 %) |
EPS: | ¥127.42 |
FY | 2022 |
Omsetning: | ¥2 696.07B |
Bruttogevinst: | ¥192.09B (7.12 %) |
EPS: | ¥127.42 |
FY | 2022 |
Omsetning: | ¥2 585.64B |
Bruttogevinst: | ¥187.47B (7.25 %) |
EPS: | ¥153.57 |
FY | 2021 |
Omsetning: | ¥2 603.26B |
Bruttogevinst: | ¥175.54B (6.74 %) |
EPS: | ¥115.75 |
Financial Reports:
No articles found.
Alfresa Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥28.00 (N/A) |
¥0 (N/A) |
¥29.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥8.75 | 2006-03-28 |
Last Dividend | ¥29.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 36 | -- |
Total Paid Out | ¥544.25 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.19 | -- |
Div. Sustainability Score | 9.59 | |
Div.Growth Potential Score | 2.59 | |
Div. Directional Score | 6.09 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9380.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8338.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7723.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6882.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6255.T | Ex Dividend Junior | 2023-08-30 | Sporadic | 0 | 0.00% | |
4972.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4185.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3382.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
2453.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
9960.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0113 | 1.500 | 9.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0212 | 1.200 | 9.29 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0671 | 1.500 | -0.365 | -0.548 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.213 | 0.800 | 8.94 | 7.15 | [1 - 3] |
quickRatioTTM | 0.923 | 0.800 | 9.28 | 7.42 | [0.8 - 2.5] |
cashRatioTTM | 0.206 | 1.500 | 9.97 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0200 | -1.500 | 9.67 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 488.93 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0646 | -1.500 | 9.74 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0724 | 1.000 | -2.13 | -2.13 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0142 | 1.000 | -1.716 | -1.716 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.897 | 1.000 | 6.13 | 6.13 | [0.2 - 2] |
assetTurnoverTTM | 1.885 | 0.800 | 0.766 | 0.613 | [0.5 - 2] |
Total Score | 9.59 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.60 | 1.000 | 8.73 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0671 | 2.50 | -0.235 | -0.548 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.432 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 143.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.798 | 1.500 | -8.66 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00951 | 1.000 | -2.26 | 0 | [0.1 - 0.5] |
Total Score | 2.59 |
Alfresa Holdings
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.